{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:31:19Z","timestamp":1770665479975,"version":"3.49.0"},"reference-count":60,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1037,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1111\/ane.12016","type":"journal-article","created":{"date-parts":[[2012,10,29]],"date-time":"2012-10-29T11:02:00Z","timestamp":1351508520000},"page":"19-28","source":"Crossref","is-referenced-by-count":50,"special_numbering":"supplement s194","title":["Zonisamide: its pharmacology, efficacy and safety in clinical trials"],"prefix":"10.1155","volume":"126","author":[{"given":"M. J.","family":"Brodie","sequence":"first","affiliation":[{"name":"Epilepsy Unit; Western Infirmary; Glasgow; Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ben-Menachem","sequence":"additional","affiliation":[{"name":"Institute for Clinical Neuroscience and Physiology; Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Chouette","sequence":"additional","affiliation":[{"name":"Eisai Ltd; Hatfield; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Eisai Ltd; Hatfield; UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,10,29]]},"reference":[{"key":"10.1111\/ane.12016-BIB0001|ane12016-cit-0001","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1248\/cpb.24.632","article-title":"Studies on substituted 1,2-benzisoxazole derivatives","volume":"24","author":"Uno","year":"1976","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1111\/ane.12016-BIB0002|ane12016-cit-0002","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1021\/jm00188a011","article-title":"Studies on 3-substituted 1,2-benzisoxazole derivatives. 6. Syntheses of 3-(sulfamoylmethyl)-1,2-benzisoxazole derivatives and their anticonvulsant activities","volume":"22","author":"Uno","year":"1979","journal-title":"J Med Chem"},{"key":"10.1111\/ane.12016-BIB0003|ane12016-cit-0003","first-page":"477","article-title":"3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile","volume":"30","author":"Masuda","year":"1980","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/ane.12016-BIB0004|ane12016-cit-0004","unstructured":"Eisai Ltd Zonegran \u00ae Summary of Product Characteristics 2012 http:\/\/www.medicines.org.uk\/emc\/medicine\/16240\/SPC\/Zonegran%20capsules"},{"key":"10.1111\/ane.12016-BIB0005|ane12016-cit-0005","unstructured":"Zonegran \u00ae Prescribing Information 2012 http:\/\/us.eisai.com\/package_inserts\/Zonegran_PI.pdf"},{"key":"10.1111\/ane.12016-BIB0006|ane12016-cit-0006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(87)90168-5","article-title":"Zonisamide enhances slow sodium inactivation in Myxicola","volume":"413","author":"Schauf","year":"1987","journal-title":"Brain Res"},{"key":"10.1111\/ane.12016-BIB0007|ane12016-cit-0007","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0920-1211(89)90041-7","article-title":"Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant","volume":"3","author":"Rock","year":"1989","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0008|ane12016-cit-0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0009|ane12016-cit-0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1059-1311(96)80104-X","article-title":"Mechanisms of T-type calcium channel blockade by zonisamide","volume":"5","author":"Kito","year":"1996","journal-title":"Seizure"},{"key":"10.1111\/ane.12016-BIB0010|ane12016-cit-0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0920-1211(92)90066-3","article-title":"Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2\u00a0+\u00a0 dependent dopamine release","volume":"13","author":"Okada","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0011|ane12016-cit-0011","first-page":"371","article-title":"Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread","volume":"47","author":"Kaneko","year":"1993","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1111\/ane.12016-BIB0012|ane12016-cit-0012","first-page":"406","article-title":"Effects of zonisamide, carbamazepine and valproate on monoamine metabolism in rat striatum and hippocampus","volume":"48","author":"Mizuno","year":"1994","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1111\/ane.12016-BIB0013|ane12016-cit-0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0920-1211(95)00078-X","article-title":"Effects of zonisamide on dopaminergic system","volume":"22","author":"Okada","year":"1995","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0014|ane12016-cit-0014","first-page":"17","article-title":"Effects of carbamazepine and zonisamide on acetylcholine levels in rat striatum","volume":"17","author":"Mizuno","year":"1997","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"key":"10.1111\/ane.12016-BIB0015|ane12016-cit-0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(98)00109-0","article-title":"Biphasic effects of zonisamide on serotonergic system in rat hippocampus","volume":"34","author":"Okada","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0016|ane12016-cit-0016","first-page":"416","article-title":"Inhibitory effect of zonisamide on human carbonic anhydrase in vitro","volume":"43","author":"Masuda","year":"1993","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/ane.12016-BIB0017|ane12016-cit-0017","first-page":"267","article-title":"Evidence against a significant implication of carbonic anhydrase inhibitory activity of zonisamide in its anticonvulsive effects","volume":"44","author":"Masuda","year":"1994","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/ane.12016-BIB0018|ane12016-cit-0018","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/wnf.0b013e3180413d7d","article-title":"Clinical pharmacology and mechanism of action of zonisamide","volume":"30","author":"Biton","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/ane.12016-BIB0019|ane12016-cit-0019","first-page":"13","article-title":"Interaction of zonisamide with benzodiazepine and GABA receptors in rat brain","volume":"39","author":"Mimaki","year":"1990","journal-title":"Med J Osaka Univ"},{"key":"10.1111\/ane.12016-BIB0020|ane12016-cit-0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures","volume":"116","author":"Ueda","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1111\/ane.12016-BIB0021|ane12016-cit-0021","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjp.0701941","article-title":"Interaction between Ca2\u00a0+\u00a0, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode","volume":"124","author":"Okada","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1111\/ane.12016-BIB0022|ane12016-cit-0022","first-page":"867","volume-title":"Antiepileptic drugs","author":"Macdonald","year":"2002","edition":"5"},{"key":"10.1111\/ane.12016-BIB0023|ane12016-cit-0023","first-page":"81","article-title":"An experimental study on the modes of appearance and disappearance of suppressive effect of antiepileptic drugs on kindled seizure","volume":"88","author":"Kakegawa","year":"1986","journal-title":"Psychiatr Neurol Jpn"},{"key":"10.1111\/ane.12016-BIB0024|ane12016-cit-0024","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1528-1157.2001.26800.x","article-title":"Contrasting effects of zonisamide and acetazolamide on amygdaloid kindling in rats","volume":"42","author":"Hamada","year":"2001","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0025|ane12016-cit-0025","first-page":"164","article-title":"Effects of 3-sulfamoylmethyl-1,2-benzisoxazole (AD-810) and some antiepileptics on the kindled seizures in the neocortex, hippocampus and amygdala in rats","volume":"249","author":"Kamei","year":"1981","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1111\/ane.12016-BIB0026|ane12016-cit-0026","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0387-7604(12)80326-3","article-title":"Anticonvulsant effects of zonisamide and phenytoin on seizure activity of the feline visual cortex","volume":"12","author":"Wada","year":"1990","journal-title":"Brain Dev"},{"key":"10.1111\/ane.12016-BIB0027|ane12016-cit-0027","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0031-6989(87)90082-8","article-title":"The genetic animal model of reflex epilepsy in the Mongolian gerbil: differential efficacy of new anticonvulsive drugs and prototype antiepileptics","volume":"19","author":"Bartoszyk","year":"1987","journal-title":"Pharmacol Res Commun"},{"key":"10.1111\/ane.12016-BIB0028|ane12016-cit-0028","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0014-2999(94)90373-5","article-title":"Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA\/2 mice","volume":"254","author":"Nakamura","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/ane.12016-BIB0029|ane12016-cit-0029","first-page":"603","article-title":"3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Electroencephalographic profile","volume":"30","author":"Ito","year":"1980","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/ane.12016-BIB0030|ane12016-cit-0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1528-1157.1986.tb03555.x","article-title":"Effects of zonisamide (AD-810) on tungstic acid gel-induced thalamic generalized seizures and conjugated estrogen-induced cortical spike-wave discharges in cats","volume":"27","author":"Ito","year":"1986","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0031|ane12016-cit-0031","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1528-1157.1995.tb01040.x","article-title":"Zonisamide: electrophysiological and metabolic changes in kainic acid-induced limbic seizures in rats","volume":"36","author":"Takano","year":"1995","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0032|ane12016-cit-0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14656560903468728","article-title":"Zonisamide in the treatment of epilepsy","volume":"11","author":"Schulze-Bonhage","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/ane.12016-BIB0033|ane12016-cit-0033","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/j.1552-4604.1998.tb04406.x","article-title":"Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures","volume":"38","author":"Kochak","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ane.12016-BIB0034|ane12016-cit-0034","first-page":"873","volume-title":"Antiepileptic drugs","author":"Shah","year":"2002","edition":"5"},{"key":"10.1111\/ane.12016-BIB0035|ane12016-cit-0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1528-1167.2007.00983.x","article-title":"Pharmacokinetics and drug interactions with zonisamide","volume":"48","author":"Sills","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0036|ane12016-cit-0036","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1248\/cpb.37.2807","article-title":"Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction","volume":"37","author":"Matsumoto","year":"1989","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1111\/ane.12016-BIB0037|ane12016-cit-0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2004.06.008","article-title":"Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients","volume":"62","author":"Ragueneau-Majlessi","year":"2004","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0038|ane12016-cit-0038","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.ftd.0000153403.99478.1f","article-title":"Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy","volume":"27","author":"Levy","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1111\/ane.12016-BIB0039|ane12016-cit-0039","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/0091270004268045","article-title":"Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy","volume":"44","author":"Levy","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/ane.12016-BIB0040|ane12016-cit-0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2165\/00003088-200544050-00005","article-title":"Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy","volume":"44","author":"Ragueneau-Majlessi","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/ane.12016-BIB0041|ane12016-cit-0041","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00007691-198609000-00010","article-title":"Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy","volume":"8","author":"Ojemann","year":"1986","journal-title":"Ther Drug Monit"},{"key":"10.1111\/ane.12016-BIB0042|ane12016-cit-0042","first-page":"880","volume-title":"Antiepileptic drugs","author":"Mather","year":"2002","edition":"5"},{"key":"10.1111\/ane.12016-BIB0043|ane12016-cit-0043","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.clinthera.2004.11.019","article-title":"Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women","volume":"26","author":"Griffith","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/ane.12016-BIB0044|ane12016-cit-0044","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0045|ane12016-cit-0045","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1212\/WNL.57.10.1774","article-title":"Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures","volume":"57","author":"Faught","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/ane.12016-BIB0046|ane12016-cit-0046","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0013-9580.2004.11403.x","article-title":"Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures","volume":"45","author":"Sackellares","year":"2004","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0047|ane12016-cit-0047","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.0013-9580.2005.14704.x","article-title":"Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0048|ane12016-cit-0048","first-page":"CD001416","article-title":"Zonisamide add-on for drug-resistant partial epilepsy","volume":"4","author":"Chadwick","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 2","key":"10.1111\/ane.12016-BIB0049|ane12016-cit-0049","first-page":"79","article-title":"Efficacy and safety of zonisamide as an adjunctive therapy for partial epilepsy uncontrolled with one antiepileptic drug","volume":"252","author":"Mayer","year":"2005","journal-title":"J Neurol"},{"key":"10.1111\/ane.12016-BIB0050|ane12016-cit-0050","unstructured":"Mayer T Silver G Remy C Lemesle-Martin M Hirsch E Efficacy and safety of zonisamide as an adjunctive therapy for partial epilepsy uncontrolled with one antiepileptic drug"},{"key":"10.1111\/ane.12016-BIB0051|ane12016-cit-0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/11539750-000000000-00000","article-title":"Efficacy and safety of adjunctive zonisamide in adult patients with refractory partial-onset epilepsy: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Lu","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1111\/ane.12016-BIB0052|ane12016-cit-0052","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1474-4422(12)70105-9","article-title":"Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomized, double-blind, non-inferiority trial","volume":"11","author":"Baulac","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12016-BIB0053|ane12016-cit-0053","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0054|ane12016-cit-0054","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0404.2008.01055.x","article-title":"Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy","volume":"118","author":"Wroe","year":"2008","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 2","key":"10.1111\/ane.12016-BIB0055|ane12016-cit-0055","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.eplepsyres.2005.11.005","article-title":"Zonisamide as adjunctive therapy for refractory partial seizures","volume":"68","author":"Brodie","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1111\/ane.12016-BIB0056|ane12016-cit-0056","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.seizure.2007.01.004","article-title":"Comparative retention rates and long-term tolerability of new antiepileptic drugs","volume":"16","author":"Chung","year":"2007","journal-title":"Seizure"},{"key":"10.1111\/ane.12016-BIB0057|ane12016-cit-0057","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eplepsyres.2011.04.012","article-title":"The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre","volume":"96","author":"Catarino","year":"2011","journal-title":"Epilepsy Res"},{"issue":"Suppl 9","key":"10.1111\/ane.12016-BIB0058|ane12016-cit-0058","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy - a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1111\/ane.12016-BIB0059|ane12016-cit-0059","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00023210-200317110-00002","article-title":"Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy","volume":"17","author":"Biton","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1111\/ane.12016-BIB0060|ane12016-cit-0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-0404.2008.01119.x","article-title":"The impact of zonisamide on weight. A clinical study in 103 patients with epilepsy","volume":"119","author":"Wellmer","year":"2009","journal-title":"Acta Neurol Scand"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12016","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12016\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:50:36Z","timestamp":1671522636000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,29]]},"references-count":60,"URL":"https:\/\/doi.org\/10.1111\/ane.12016","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,29]]}}}